Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted panel sequencing in pediatric primary cardiomyopathy supports a critical role of TNNI3
Jirko Kühnisch, Christopher Herbst, Nadya Al‐Wakeel‐Marquard, et al.
Clinical Genetics (2019) Vol. 96, Iss. 6, pp. 549-559
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Exploring TTN variants as genetic insights into cardiomyopathy pathogenesis and potential emerging clues to molecular mechanisms in cardiomyopathies
Amir Ghaffari Jolfayi, Erfan Kohansal, Serwa Ghasemi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Pathogenic Variants Associated With Dilated Cardiomyopathy Predict Outcome in Pediatric Myocarditis
Franziska Seidel, Manuel Holtgrewe, Nadya Al‐Wakeel‐Marquard, et al.
Circulation Genomic and Precision Medicine (2021) Vol. 14, Iss. 4
Open Access | Times Cited: 52
Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy
Gabrielle Norrish, Aoife Cleary, Ella Field, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 20, pp. 1986-1997
Open Access | Times Cited: 29
Targeting the population for gene therapy with MYBPC3
Lucie Carrier
Journal of Molecular and Cellular Cardiology (2020) Vol. 150, pp. 101-108
Closed Access | Times Cited: 35
Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19
Yun Tan, Wei Zhang, Zhaoqin Zhu, et al.
Cell Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 28
Advances in Therapeutic Targets and Traditional Chinese Medicine for Cardiomyopathy
Shuo Yang, Shuai‐nan Zhang, Xu‐zhao Li
Phytotherapy Research (2025)
Closed Access
Advantages and Perils of Clinical Whole-Exome and Whole-Genome Sequencing in Cardiomyopathy
Francesco Mazzarotto, Iacopo Olivotto, Roddy Walsh
Cardiovascular Drugs and Therapy (2020) Vol. 34, Iss. 2, pp. 241-253
Closed Access | Times Cited: 31
Homozygous TNNI3 Mutations and Severe Early Onset Dilated Cardiomyopathy: Patient Report and Review of the Literature
Ugo Sorrentino, Ilaria Gabbiato, Chiara Canciani, et al.
Genes (2023) Vol. 14, Iss. 3, pp. 748-748
Open Access | Times Cited: 10
Epigenomic signature of major congenital heart defects in newborns with Down syndrome
Julia S. Mouat, Shaobo Li, Swe Swe Myint, et al.
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 10
Genetic excision of the regulatory cardiac troponin I extension in high–heart rate mammal clades
William Joyce, Kai He, Mengdie Zhang, et al.
Science (2024) Vol. 385, Iss. 6716, pp. 1466-1471
Closed Access | Times Cited: 3
Genetic Evaluation of A Nation-Wide Dutch Pediatric DCM Cohort: The Use of Genetic Testing in Risk Stratification
Marijke H. van der Meulen, Johanna C. Herkert, Susanna L. den Boer, et al.
Circulation Genomic and Precision Medicine (2022)
Open Access | Times Cited: 15
Pathogenic Variants in Cardiomyopathy Disorder Genes Underlie Pediatric Myocarditis—Further Impact of Heterozygous Immune Disorder Gene Variants?
Franziska Seidel, Kai Thorsten Laser, Karin Klingel, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 7, pp. 216-216
Open Access | Times Cited: 14
Advancing physiological maturation in human induced pluripotent stem cell-derived cardiac muscle by gene editing an inducible adult troponin isoform switch
Matthew Wheelwright, Jennifer Mikkila, Fikru B. Bedada, et al.
Stem Cells (2020) Vol. 38, Iss. 10, pp. 1254-1266
Open Access | Times Cited: 20
Genetic variant burden and adverse outcomes in pediatric cardiomyopathy
Danielle S. Burstein, J. William Gaynor, Heather Griffis, et al.
Pediatric Research (2020) Vol. 89, Iss. 6, pp. 1470-1476
Open Access | Times Cited: 18
Prdm16 mutation determines sex-specific cardiac metabolism and identifies two novel cardiac metabolic regulators
Jirko Kühnisch, Simon Theisen, Josephine Dartsch, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 18, pp. 2902-2916
Open Access | Times Cited: 6
Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy
Nadya Al‐Wakeel‐Marquard, Franziska Seidel, Christopher Herbst, et al.
International Journal of Cardiology (2021) Vol. 333, pp. 219-225
Closed Access | Times Cited: 13
Reduced Systolic Function and Not Genetic Variants Determine Outcome in Pediatric and Adult Left Ventricular Noncompaction Cardiomyopathy
Alina Schultze-Berndt, Jirko Kühnisch, Christopher Herbst, et al.
Frontiers in Pediatrics (2021) Vol. 9
Open Access | Times Cited: 12
Molecular Diagnosis of Primary Cardiomyopathy in 231 Unrelated Pediatric Cases by Panel-Based Next-Generation Sequencing: A Major Focus on Five Carriers of Biallelic TNNI3 Pathogenic Variants
Alexandre Janin, Thomas Pérouse de Montclos, Karine Nguyen, et al.
Molecular Diagnosis & Therapy (2022) Vol. 26, Iss. 5, pp. 551-560
Closed Access | Times Cited: 7
The road to physiological maturation of stem cell-derived cardiac muscle runs through the sarcomere
Joseph M. Metzger
Journal of Molecular and Cellular Cardiology (2022) Vol. 170, pp. 117-120
Open Access | Times Cited: 5
Left Ventricular Noncompaction in Children: The Role of Genetics, Morphology, and Function for Outcome
Sabine Klaassen, Jirko Kühnisch, Alina Schultze-Berndt, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 7, pp. 206-206
Open Access | Times Cited: 5
Epigenomic signature of major congenital heart defects in newborns with Down syndrome
Julia S. Mouat, Shaobo Li, Swe Swe Myint, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Midwall Fibrosis and Cardiac Mechanics: Rigid Body Rotation Is a Novel Marker of Disease Severity in Pediatric Primary Dilated Cardiomyopathy
Nadya Al‐Wakeel‐Marquard, Franziska Seidel, Jirko Kühnisch, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 4
Genetic study of pediatric hypertrophic cardiomyopathy in Egypt
Rania Darwish, Alireza Haghighi, Zeinab Salah Seliem, et al.
Cardiology in the Young (2020) Vol. 30, Iss. 12, pp. 1910-1916
Closed Access | Times Cited: 4
Identification of a novel likely pathogenic TPM1 variant linked to hypertrophic cardiomyopathy in a family with sudden cardiac death
Amir Azimi, Mahdieh Soveizi, Alireza Salmanipour, et al.
ESC Heart Failure (2024)
Open Access
Homozygous TNNI3 frameshift variant in a consanguineous family with lethal infantile dilated cardiomyopathy
Lilia Kraoua, Assaad Louati, Sarra Ben Ahmed, et al.
Molecular Genetics & Genomic Medicine (2024) Vol. 12, Iss. 6
Open Access
Page 1 - Next Page

Scroll to top